Successful delivery of chemotherapy to treat small-cell prostate cancer in a patient undergoing haemodialysis - Abstract

We report on the successful treatment of small-cell prostate cancer in a patient undergoing haemodialysis.

The therapeutic regimen included 300 mg/m2 of carboplatin and 50 mg/m2 of etoposide coupled with radical radiotherapy. Adjustments to the patient's haemodialysis prescription included the use of high flux, a larger dialyser surface area and an increased dialysis time. The parameters used aided tolerance to the drug, allowing the delivery of safe, effective treatment. At an interval of over 12 months post-treatment the patient shows no clinical evidence of recurrent disease. This case provides evidence to encourage the use of chemotherapy in otherwise potentially undertreated haemodialysed patients.

Written by:
McPartlin A, Grimaldo C, Lyons J, Burke D, Mitra S, Choudhury A.   Are you the author?
The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK; Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.

Reference: Clin Kidney J. 2014 Dec;7(6):593-4.
doi: 10.1093/ckj/sfu097


PubMed Abstract
PMID: 25859378

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe